Sickle cell disease persists in Nigeria despite decades of awareness

Nigeria continues to face a significant burden of sickle cell disease (SCD), with an estimated 150,000 infants born with the condition annually, according to the Federal Ministry of Health and Social Welfare.

Despite decades of public awareness campaigns encouraging genotype testing and informed marriage decisions, health experts observe that this awareness has not adequately translated into effective care, early diagnosis, or an improved quality of life for individuals living with SCD. Major gaps persist in Nigeria's response, including weak newborn screening protocols, limited access to necessary treatments, under-resourced primary healthcare facilities, and lingering misconceptions about the disease.

Medical and maternal health experts stress that public health discussions must evolve beyond focusing solely on genotype compatibility to prevent new cases. Happiness Akinde, a medical doctor, stated that conversations should also prioritize the millions already living with the disease. "Genotype awareness has been extremely important because it helps prevent new cases of sickle cell disease through informed reproductive decisions. However, there is a growing recognition that awareness efforts should also focus on people already living with the condition," she explained.

Akinde further noted that knowledge alone does not prevent sickle cell crises, which can be triggered by infections, dehydration, stress, or poor sleep, even in patients who adhere to medical advice. Reducing the frequency of these painful episodes requires a combination of patient education, preventive treatments, reliable healthcare services, and robust social support systems. Conversations about hydration, infection prevention, medication adherence, nutrition, mental health, routine screenings, and early complication recognition are as crucial as genotype counseling.

Beyond medical challenges, socioeconomic factors significantly worsen outcomes for many patients. Families often struggle to afford medications, transportation to hospitals, and essential laboratory tests. Limited access to healthcare facilities and a lack of health insurance coverage further complicate regular care, highlighting that effective management extends beyond personal responsibility and requires systemic support.

“

Genotype awareness has been extremely important because it helps prevent new cases of sickle cell disease through informed reproductive decisions. However, there is a growing recognition that awareness efforts should also focus on people already living with the condition.